145 related articles for article (PubMed ID: 11000577)
1. Chemosensitivity in childhood brain tumours in vitro: evidence of differential sensitivity to lomustine (CCNU) and vincristine.
Lewandowicz GM; Harding B; Harkness W; Hayward R; Thomas DG; Darling JL
Eur J Cancer; 2000 Oct; 36(15):1955-64. PubMed ID: 11000577
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
[TBL] [Abstract][Full Text] [Related]
3. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of primary brain tumors.
Levin VA
Neurol Clin; 1985 Nov; 3(4):855-66. PubMed ID: 3001491
[TBL] [Abstract][Full Text] [Related]
5. The chemotherapeutic response of a murine (VM) model of human glioma.
Bradford R; Darling JL; Thomas DG
Br J Cancer; 1990 Jan; 61(1):46-50. PubMed ID: 2297489
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide.
Sankar A; Thomas DG; Darling JL
Anticancer Drugs; 1999 Feb; 10(2):179-85. PubMed ID: 10211548
[TBL] [Abstract][Full Text] [Related]
7. The VM model of glioma: preparation of multicellular tumour spheroids (MTS) and their response to chemotherapy.
Bradford R; Darling JL; Sier N; Thomas DG
J Neurooncol; 1990 Oct; 9(2):105-14. PubMed ID: 2262797
[TBL] [Abstract][Full Text] [Related]
8. Procarbazine, lomustine, vincristine combination may be effective in adult medulloblastoma patients with systemic metastases.
Cakar M; Aksoy S; Kilickap S; Harputluoglu H; Erman M
J Neurooncol; 2005 Nov; 75(2):233-4. PubMed ID: 16132496
[No Abstract] [Full Text] [Related]
9. Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.
Shapiro WR; Young DF
Trans Am Neurol Assoc; 1976; 101():217-20. PubMed ID: 1028239
[No Abstract] [Full Text] [Related]
10. Single-agent chemotherapy of brain tumors. A five-year review.
Wilson CB; Gutin P; Boldrey EB; Drafts D; Levin VA; Enot KJ
Arch Neurol; 1976 Nov; 33(11):739-44. PubMed ID: 185991
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
Buckner JC; Gesme D; O'Fallon JR; Hammack JE; Stafford S; Brown PD; Hawkins R; Scheithauer BW; Erickson BJ; Levitt R; Shaw EG; Jenkins R
J Clin Oncol; 2003 Jan; 21(2):251-5. PubMed ID: 12525516
[TBL] [Abstract][Full Text] [Related]
12. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas.
Kim L; Hochberg FH; Thornton AF; Harsh GR; Patel H; Finkelstein D; Louis DN
J Neurosurg; 1996 Oct; 85(4):602-7. PubMed ID: 8814163
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of medulloblastoma and ependymoma in childhood].
Terheggen HG
Dtsch Med Wochenschr; 1977 Jun; 102(24):899-901. PubMed ID: 872757
[No Abstract] [Full Text] [Related]
14. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
Levin VA; Crafts DC; Wilson CB; Schultz MJ; Boldrey EB; Enot KJ; Pischer TL; Seager M; Elashoff RM
Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210
[TBL] [Abstract][Full Text] [Related]
15. Brain tumors in children.
Ertel IJ; Boesel C
Pediatr Ann; 1978 Aug; 7(8):560-9. PubMed ID: 211479
[No Abstract] [Full Text] [Related]
16. Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma.
Thomas DG; Darling JL; Paul EA; Mott TJ; Godlee JN; Tobias JS; Capra LG; Collins CD; Mooney C; Bozek T
Br J Cancer; 1985 Apr; 51(4):525-32. PubMed ID: 3978031
[TBL] [Abstract][Full Text] [Related]
17. [Interim results of the SIOP study (author's transl)].
Bloom HJ; Neidhardt MK
Monatsschr Kinderheilkd (1902); 1978 Nov; 126(11):652-4. PubMed ID: 723874
[TBL] [Abstract][Full Text] [Related]
18. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
Haselsberger K; Peterson DC; Thomas DG; Darling JL
Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy: the agents in current use.
Levin VA; Wilson CB
Semin Oncol; 1975 Mar; 2(1):63-7. PubMed ID: 795035
[No Abstract] [Full Text] [Related]
20. Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?
Lassman AB
CNS Oncol; 2015; 4(5):341-6. PubMed ID: 26544062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
